Jamshid H. Karimov

Jamshid H. Karimov

Auto-generated profile, based on publicly available information

Jamshid H. Karimov

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JKJamshid H. Karimov
Jamshid H. Karimov
DHDavid J. Horvath
David J. Horvath
NBNicole Byram
Nicole Byram
GSGengo Sunagawa
Gengo Sunagawa
BKBarry D. Kuban
Barry D. Kuban
KFKiyotaka Fukamachi
Kiyotaka Fukamachi

23 September 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
TKTaiyo Kuroda
Taiyo Kuroda
CMChihiro Miyagi
Chihiro Miyagi
KFKiyotaka Fukamachi
Kiyotaka Fukamachi
JKJamshid H. Karimov
Jamshid H. Karimov
The importance of right heart failure (RHF) treatment is magnified over the years due to the increased risk of mortality. Additionally, the multifactorial origin and pathophysiological mechanisms of RHF render this clinical condition and the choices for appropriate therapeutic target strategies remain to be complex. The recent change in the United Network for Organ Sharing (UNOS) allocation criteria of heart transplant may have impacted for the number of left ventricular assist devices (LVADs), but LVADs still have been widely used to treat advanced heart failure, and 4.1 to 7.4% of LVAD patients require a right ventricular assist device (RVAD). In addition, patients admitted with primary left ventricular failure often need right ventricular support. Thus, there is unmet need for temporary or long-term support RVAD implantation exists. In RHF treatment with mechanical circulatory support (MCS) devices, the timing of the intervention and prediction of duration of the support play a major role in successful treatment and outcomes. In this review, we attempt to describe the prevalence and pathophysiological mechanisms of RHF origin, and provide an overview of existing treatment options, strategy and device choices for MCS treatment for RHF.

8 April 2017 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
KFKiyotaka Fukamachi
Kiyotaka Fukamachi
JKJamshid H. Karimov
Jamshid H. Karimov
GSGengo Sunagawa
Gengo Sunagawa
DHDavid J. Horvath
David J. Horvath
NBNicole Byram
Nicole Byram
NMNader Moazami
Nader Moazami

6 January 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
TKTaiyo Kuroda
Taiyo Kuroda
CMChihiro Miyagi
Chihiro Miyagi
KFKiyotaka Fukamachi
Kiyotaka Fukamachi
JKJamshid H. Karimov
Jamshid H. Karimov
In contrast to the advanced development of the left ventricular assist device (LVAD) therapy for advanced heart failure, the mechanical circulatory support (MCS) with biventricular assist device (BVAD) and total artificial heart (TAH) options remain challenging. The treatment strategy of BVAD and TAH therapy largely depends on the support duration. For example, an extracorporeal centrifugal pump, typically referred to as a temporary surgical extracorporeal right ventricular assist device, is implanted for the short term with acute right ventricular failure following LVAD implantation. Meanwhile, off-label use of a durable implantable LVAD is a strategy for long-term right ventricular support. Hence, this review focuses on the current treatment strategies and clinical outcomes based on each ventricle support duration. In addition, the issue of heart failure post-heart transplantation (post-HT) is explored. We will discuss MCS therapy options for post-HT recipients.

3 April 2018 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
KFKiyotaka Fukamachi
Kiyotaka Fukamachi
JKJamshid H. Karimov
Jamshid H. Karimov
NBNicole A. Byram
Nicole A. Byram
GSGengo Sunagawa
Gengo Sunagawa
RDRaymond Dessoffy
Raymond Dessoffy
DHDavid J. Horvath
David J. Horvath

9 May 2019 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
TMTakuma Miyamoto
Takuma Miyamoto
NBNicole Byram
Nicole Byram
JKJamshid H. Karimov
Jamshid H. Karimov
JAJoseph Adams
Joseph Adams
RDRaymond Dessoffy
Raymond Dessoffy
KFKiyotaka Fukamachi
Kiyotaka Fukamachi